PATENT CLAIM ANALYSIS

Application Number: 15956124
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "635000"]

Abstract:
The invention relates to a method of treating or preventing a condition in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof. The invention further relates to a method of improving a physiological function in a subject, comprising administering to the subject an acceptable composition comprising meglumine or a salt thereof.

Claim (Index 1):
A composition comprising meglumine or a salt thereof and a therapeutic agent selected from the group consisting of \u03b1-glucosidase inhibitors, lipase inhibitors, sulfonyl ureas, meglitinides, biguanides, thiazolidinediones, pramlintide, incretin mimetics, DPP-IV inhibitors, a salt thereof, and any combinations thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 2.21429
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15413455', '13962645', '14673259', '10198706', '11818997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7614098151027254
- 35 USC 102 Novelty (BERT): 0.5196141880855638
- Combined Prediction Score: 0.7372302524010094
- Mean Citation Score: 256.46477400000003
- Max Citation Score: 310.92578
- Similarity Product: 217.8631504215741

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test